PATIENTS CARE ABOUT CURES, NOT CONFLICT OF INTEREST
More than a third of doctors who sit on review boards overseeing the integrity of clinical trials do not bother to disclose a financial stake in the outcome, a study in the New England Journal of Medicine has shown. However this does not shock cancer patients. In the same journal another study found that 80% were “not worried at all” if a doctor profited from a tested drug. In fact, most patients said that they opposed bans on such relationships. The author of the study said that this was quite understandable since participants in clinical trials “are very vulnerable, have a serious problem and want someone to care for it.”
Michael Cook edits BioEdge, a bioethics newsletter, and MercatorNet, an on-line magazine whose focus is human dignity. He writes from Sydney, Australia.
Latest posts by Michael Cook (see all)
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
The world’s most expensive drug is a cure for haemophilia
The US Food and Drug Administration has approved the world’s most expensive drug. Per dose, Hemgenix will cost US$3.5 million....
‘I felt like a knife had been put into my heart’: Down syndrome woman
The UK Court of Appeal has dismissed a legal challenge brought by a woman with Down syndrome against a provision...
Dutch sperm donor may have fathered 400 children
A Dutch sperm donor who advertised his services online has fathered at least 80 children and possibly as many as...
4 women die in Indian sterilization camp. Authorities very sorry.
Double-puncture laparoscopy procedures are very popular amongst Indian women who want permanent sterilization. “The surgery is preferred over other sterilisation...
A lonely euthanasia death on Vancouver Island
In assisted dying, it would be unethical to carry out clinical trials. How could you design an experiment in which...
Should the venerable NEJM be renamed?
The world’s most prestigious medical journal, the New England Journal of Medicine, is digging its heels in over the controversial...